GEN Exclusives

More »

GEN News Highlights

More »
Sep 11, 2007

GeneGo and the Cystic Fibrosis Foundation Are Building Software to Aid Research

  • GeneGo and the Cystic Fibrosis Foundation are partnering to develop software for the integration and analysis of cystic fibrosis data. The product, which will be called MetaMiner (CF), is intended to be used by medicinal chemists and biologists active in preclinical areas of high-content and high-throughput screening, bioassays, and hit-to-lead research.

    MetaMiner (CF) is expected to be available by February of 2008 to cystic fibrosis academic researchers and drug development collaborators through access licenses. It will include cystic fibrosis-specific OMICs and small experiments content annotated by GeneGo, disease maps, and networks.

    GeneGo products such as MetaCore, MetaDrug, MetaLink, and MapEditor will be incorporated in the product. “This collaboration is the first in the series of disease-centered MetaMiner projects that integrate our existing data analysis tools, OMICs data warehousing, and disease-specific knowledge base,” points out Julie Bryant, GeneGo's vp of business development.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?